COVID-19 Vaccine for Children after MIS-C Appears Safe

Published: 01/04/2023

Sources:
  • Miscellaneous
Relevant To:
  • Urgent Care,
  • Medical Office,
  • Critical Access Hospitals,
  • Hospitals,
  • Ambulatory Care,
  • Rural Health Clinics

According to a new study sponsored by the National Institutes of Health, children and adolescents who received a COVID-19 vaccination following multisystem inflammatory syndrome (MIS-C) found that there were no reports of serious complications, including myocarditis or MIS-C reoccurrence. About half of participants experienced mild and typical reactions, including arm soreness and fatigue. The findings will publish today in JAMA Network Open.

The multicenter, observational study, the largest …

Sign Up for Free Trial